Oppenheimer Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.3M | Sell |
27,079
-238
| -0.9% | -$110K | 0.15% | 152 |
|
|
2026
Q1 | $13.1M | Sell |
27,317
-1,285
| -4% | -$658K | 0.15% | 165 |
|
|
2025
Q4 | $16.1M | Sell |
28,602
-7,355
| -20% | -$4.18M | 0.2% | 121 |
|
|
2025
Q3 | $18.5M | Sell |
35,957
-1,743
| -5% | -$761K | 0.2% | 123 |
|
|
2025
Q2 | $11.8M | Sell |
37,700
-651
| -2% | -$195K | 0.14% | 179 |
|
|
2025
Q1 | $11.7M | Sell |
38,351
-1,110
| -3% | -$373K | 0.15% | 163 |
|
|
2024
Q4 | $13.1M | Sell |
39,461
-6,012
| -13% | -$2.04M | 0.16% | 147 |
|
|
2024
Q3 | $15.2M | Buy |
45,473
+2,675
| +6% | +$1.02M | 0.18% | 140 |
|
|
2024
Q2 | $17.6M | Buy |
42,798
+4,168
| +11% | +$1.65M | 0.23% | 98 |
|
|
2024
Q1 | $15.6M | Sell |
38,630
-6,211
| -14% | -$2.18M | 0.23% | 105 |
|
|
2023
Q4 | $13.7M | Buy |
44,841
+13,725
| +44% | +$3.7M | 0.19% | 129 |
|
|
2023
Q3 | $7.53M | Sell |
31,116
-1,913
| -6% | -$489K | 0.12% | 210 |
|
|
2023
Q2 | $7.93M | Buy |
33,029
+10,546
| +47% | +$2.19M | 0.12% | 209 |
|
|
2023
Q1 | $4.23M | Sell |
22,483
-1,191
| -5% | -$246K | 0.07% | 303 |
|
|
2022
Q4 | $5.03M | Sell |
23,674
-2,504
| -10% | -$500K | 0.08% | 265 |
|
|
2022
Q3 | $4.11M | Sell |
26,178
-1,951
| -7% | -$311K | 0.07% | 284 |
|
|
2022
Q2 | $4.21M | Buy |
28,129
+4,275
| +18% | +$619K | 0.07% | 287 |
|
|
2022
Q1 | $3.9M | Sell |
23,854
-2,976
| -11% | -$491K | 0.06% | 351 |
|
|
2021
Q4 | $5.84M | Buy |
26,830
+2,903
| +12% | +$608K | 0.08% | 277 |
|
|
2021
Q3 | $4.53M | Buy |
23,927
+815
| +4% | +$149K | 0.06% | 322 |
|
|
2021
Q2 | $4.08M | Buy |
23,112
+344
| +2% | +$59.4K | 0.06% | 342 |
|
|
2021
Q1 | $3.73M | Buy |
22,768
+5,601
| +33% | +$857K | 0.06% | 341 |
|
|
2020
Q4 | $2.39M | Buy |
17,167
+3,533
| +26% | +$445K | 0.04% | 428 |
|
|
2020
Q3 | $1.52M | Buy |
13,634
+1,027
| +8% | +$119K | 0.03% | 502 |
|
|
2020
Q2 | $1.17M | Buy |
12,607
+2,574
| +26% | +$219K | 0.02% | 556 |
|
|
2020
Q1 | $736K | Buy |
10,033
+4,115
| +70% | +$357K | 0.02% | 634 |
|
|
2019
Q4 | $497K | Buy |
5,918
+624
| +12% | +$48.3K | 0.01% | 816 |
|
|
2019
Q3 | $445K | Sell |
5,294
-1,061
| -17% | -$80.2K | 0.01% | 831 |
|
|
2019
Q2 | $416K | Buy |
6,355
+2,095
| +49% | +$121K | 0.01% | 863 |
|
|
2019
Q1 | $251K | Buy |
4,260
+517
| +14% | +$30.9K | 0.01% | 977 |
|
|
2018
Q4 | $198K | Buy |
+3,743
| New | +$205K | ﹤0.01% | 1017 |
|
|
2017
Q4 | – | Sell |
-55
| Closed | -$2K | – | 1313 |
|
|
2017
Q3 | $2K | Hold |
55
| – | – | ﹤0.01% | 1625 |
|
|
2017
Q2 | $2K | Sell |
55
-47
| -46% | -$1.32K | ﹤0.01% | 1622 |
|
|
2017
Q1 | $3K | Buy |
+102
| New | +$3.29K | ﹤0.01% | 1621 |
|
Other funds holding MEDP
WA
Oppenheimer Asset Management's MEDP Position: Q2 2026 in Review
Oppenheimer Asset Management reduced its Medpace (MEDP) stake by 0.87% in Q2 2026, selling an estimated $110K and leaving 27,079 shares worth $14.3M. The position accounts for 0.15% of the portfolio, ranked #152.
Oppenheimer Asset Management first reported a position in MEDP in Q1 2017 and has held it in 34 quarters since. The position peaked at $18.5M in Q3 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Oppenheimer Asset Management held 27,079 shares of Medpace worth $14.3M as of Q2 2026.
- Oppenheimer Asset Management sold 238 Medpace shares in Q2 2026, an estimated $110K.
- Medpace made up 0.15% of Oppenheimer Asset Management's portfolio in Q2 2026, its #152 holding.
- Oppenheimer Asset Management first reported a position in Medpace in Q1 2017 and has held it in 34 quarters since.
- Oppenheimer Asset Management's Medpace position peaked at $18.5M in Q3 2025.
- 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.